Home » Topics » BioWorld Science

BioWorld Science
RSS

eXIthera Pharmaceuticals divulges coagulation factor XIa and kallikrein inhibitors

Sep. 3, 2019

Eli Lilly and Company describes PDE1 inhibitors

Sep. 3, 2019

Crinetics Pharmaceuticals identifies somatostatin SST5 receptor agonists

Sep. 3, 2019

TREM2 correlates with slow decline in AD

Sep. 3, 2019

Daiichi Sankyo presents new analgesics

Sep. 3, 2019

HIV rebound shows diverse sources, identical virus

Sep. 3, 2019

KBP Biosciences patents new bacterial LpxC inhibitors

Sep. 3, 2019

UCn2 gene transfer improves diabetes-related left-ventricular dysfunction in mice

Sep. 3, 2019

Eicosis' soluble epoxide hydrolase inhibitor EC-5026 to enter the clinic

Sep. 3, 2019

Lower affinity means lower affinity, but higher persistence, for CAR T cells

Sep. 3, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Nov. 12, 2025.
Could restricting diversity efforts stall women’s health research?
BioWorld
Recent progress in redressing the historical underfunding and neglect of women’s health could be undermined by the backlash against diversity, equity and...
Alkermes’ alixorexton hits endpoints in narcolepsy phase II
BioWorld
Alkermes plc’s placebo-controlled phase II study of alixorexton in treating narcolepsy type 2 (NT2) hit its dual primary endpoints, producing statistically...
Pazdur ‘optimal fit’ to lead FDA’s CDER
BioWorld
In reaching within to name 26-year FDA veteran Richard Pazdur as the next CDER director, FDA Commissioner Marty Makary likely chose the best possible person to...